Azashine 200mg Tablet
Marketer
Hetero Healthcare Limited
Salt Composition
Azacitidine (200mg)
Overview Azashine 200mg Tablet
Azashine 200mg tablets are indicated in the management of specific blood cancers. This medication treats adult patients across all Myelodysplastic Syndrome (MDS) subtypes. Other uses may be determined by your physician. Azashine 200mg tablets can be administered with or without food, but consistent daily timing is recommended. Dosage and frequency will be individualized by your doctor based on your condition and may vary. Adhere strictly to your prescribed regimen; incorrect usage or overdosage can result in severe adverse effects. Therapeutic benefits might not be apparent for several weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, fatigue, and pyrexia. Report any concerning symptoms to your physician; management strategies may be available. Vaccination during treatment requires prior medical consultation. Regular blood tests monitoring blood cell counts, as well as liver, kidney, and cardiac function, are necessary. Inform your doctor of any pre-existing hepatic or renal impairment, or concurrent use of anti-infectives, before commencing treatment. Drug interactions are possible; disclose all medications to your physician. This medication is contraindicated during pregnancy and lactation.
Uses of Azashine 200mg Tablet
Myelodysplastic syndrome: Blood cancer therapies
Major Benefits of Azashine 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Azashine 200mg Tablet whole; do not chew, crush, or divide it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Azashine 200mg Tablet:
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Azashine 200mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Azashine 200mg Tablet whole; do not crush, chew, or divide it. Consumption with or without food is acceptable, but consistent timing is recommended.
How Azashine 200mg Tablet works:
Azashine 200mg tablets are used in cancer treatment. Their mechanism involves disrupting the genetic makeup (DNA and RNA) of leukemia cells, halting their proliferation. This action leads to cancer cell death and facilitates the healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Azashine 200mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Azashine 200mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Azashine 200mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Azashine 200mg Tablet side effects, including fatigue. Azashine 200mg Tablets can induce drowsiness, potentially impacting driving capabilities.
KidneyCAUTION
For individuals with kidney impairment, Azashine 200mg Tablets require careful administration. Dosage modification of Azashine 200mg Tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Azashine 200mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Azashine 200mg tablets are contraindicated in individuals with advanced hepatocellular carcinoma.
What if you forget to take Azashine 200mg Tablet :
NA
Facts to Know About Azashine 200mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavioral Class | Metabolic inhibitors |
3,018 People bought this recently